Puzzling Results From HIV Vaccine Trial
Posted on: Monday, 3 December 2007, 12:00 CST
A potential HIV vaccine that recently failed a clinical trial in the United States may increase some people's chance of catching the virus that causes AIDS.
Top government and drug industry scientists are currently reviewing data from the trial, which unexpectedly found more HIV infections among study participants who had previously been exposed to a common virus called adenovirus, The Washington Times reported Monday.
We're trying very hard to understand the data more fully and completely, says Nalini Saligram, a spokeswoman for Merck, co-sponsor of the STEP vaccine trial.
Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Disease, called the trial results both disappointing and puzzling.
The trial involved 3,000 participants between the ages of 18 and 45 who were at risk of HIV infection based on their behavior.
It ended in September after researchers determined the vaccine failed to decrease either the chance of HIV infection or the amount of virus in people who became infected while taking it.
Source: United Press International
Related Articles
- Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its 'Fillanthropy(TM) Program'
- Successful Results for Mymetics Corporation's Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
- Phase 1 Clinical Trials For HIV/AIDS Vaccine Underway
- Excellent Results Received From GeoVax's Full-Dose HIV/AIDS Vaccine Trial
- U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine Program
- GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
- Pre-Clinical Data on Recent Advances With HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
- The Uganda Virus Research Institute (UVRI), in Collaboration With the International AIDS Vaccine Initiative (IAVI) and Targeted Genetics, Launches HIV/AIDS Vaccine Trial in Entebbe, Uganda
- Vical Initiates Trial of DNA Vaccine
- Potential HIV/AIDS Vaccine Gets More Tests
User Comments (0)

RSS Feeds